Matches in SemOpenAlex for { <https://semopenalex.org/work/W2947693678> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W2947693678 abstract "e20710 Background: Currently, prognostic markers associated with immunotherapy treatment outcomes in patients with metastatic NSCLC include PDL-1 expression, tumor mutational burden (TBM), and neutrophil to lymphocyte ratio (NLR). In this study we examine the influence of pretreatment changes in weight, BMI, and NLR in 237 patients treated with anti-PD-1/PDL-1 therapy (ICI) at our institution. Methods: This was a retrospective analysis of previously-treated stage IV NSCLC patients who received ICI. Pretreatment (≥ 6 weeks before starting therapy) values of weight, BMI, and NLR were compared to baseline values and NLR was analyzed as continuum and according to standard cutoffs of 3.5 and 5. The same variables were correlated with progression-free survival (PFS) and overall survival (OS) using the Log-Rank test. Results: 237 patients were analyzed: 45% were male, 73% were Caucasian, 72% were former smokers, and 25% were age ≥ 75 years. 148 patients had pretreatment NLR values. Of these, 32% had a ratio < 3.5 and 54% had ratio < 5. 34% had increased NLR at baseline, the majority of which (48/77) had a > 5% increase. 187 patients had pretreatment weight and BMI. Of these, 14% had a pretreatment BMI < 20. 71% had a negative change in BMI and 29% had a > 5% decrease in BMI. 65% had a negative change in weight and 26% had a > 5% decrease in weight. BMI decrease greater than 5% (p = 0.0039), negative weight change (p = 0.0371), and pretreatment NLR > 5 (p = 0.0136) were associated with shorter PFS. Change in NLR trended towards decreased PFS but was not statistically significant (p = 0.07) though only 77 of 237 patients had both values available. There was no statistical PFS difference between patients less than or ≥ 75 years old. Conclusions: The results suggest that decrease in pretreatment BMI and weight along with high baseline NLR are associated with significantly shorter PFS in NSCLC treated with anti-PD-1/PDL-1 therapy. If confirmed, these observations raise the possibility that specific treatment which reverses cancer associated weight loss might enhance effectiveness of immunotherapy." @default.
- W2947693678 created "2019-06-07" @default.
- W2947693678 creator A5008913834 @default.
- W2947693678 creator A5017312893 @default.
- W2947693678 creator A5024343309 @default.
- W2947693678 creator A5032871452 @default.
- W2947693678 creator A5040798556 @default.
- W2947693678 creator A5043971397 @default.
- W2947693678 creator A5053344068 @default.
- W2947693678 date "2019-05-20" @default.
- W2947693678 modified "2023-09-26" @default.
- W2947693678 title "Decreasing BMI/weight immediately prior to starting anti-PD-1/PDL-1 monoclonal antibodies for treatment for stage IV non-small cell lung cancer is associated with shorter progression-free survival." @default.
- W2947693678 doi "https://doi.org/10.1200/jco.2019.37.15_suppl.e20710" @default.
- W2947693678 hasPublicationYear "2019" @default.
- W2947693678 type Work @default.
- W2947693678 sameAs 2947693678 @default.
- W2947693678 citedByCount "0" @default.
- W2947693678 crossrefType "journal-article" @default.
- W2947693678 hasAuthorship W2947693678A5008913834 @default.
- W2947693678 hasAuthorship W2947693678A5017312893 @default.
- W2947693678 hasAuthorship W2947693678A5024343309 @default.
- W2947693678 hasAuthorship W2947693678A5032871452 @default.
- W2947693678 hasAuthorship W2947693678A5040798556 @default.
- W2947693678 hasAuthorship W2947693678A5043971397 @default.
- W2947693678 hasAuthorship W2947693678A5053344068 @default.
- W2947693678 hasConcept C126322002 @default.
- W2947693678 hasConcept C143998085 @default.
- W2947693678 hasConcept C146357865 @default.
- W2947693678 hasConcept C151730666 @default.
- W2947693678 hasConcept C159654299 @default.
- W2947693678 hasConcept C203014093 @default.
- W2947693678 hasConcept C2776256026 @default.
- W2947693678 hasConcept C2780739268 @default.
- W2947693678 hasConcept C3019894029 @default.
- W2947693678 hasConcept C542903549 @default.
- W2947693678 hasConcept C71924100 @default.
- W2947693678 hasConcept C86803240 @default.
- W2947693678 hasConceptScore W2947693678C126322002 @default.
- W2947693678 hasConceptScore W2947693678C143998085 @default.
- W2947693678 hasConceptScore W2947693678C146357865 @default.
- W2947693678 hasConceptScore W2947693678C151730666 @default.
- W2947693678 hasConceptScore W2947693678C159654299 @default.
- W2947693678 hasConceptScore W2947693678C203014093 @default.
- W2947693678 hasConceptScore W2947693678C2776256026 @default.
- W2947693678 hasConceptScore W2947693678C2780739268 @default.
- W2947693678 hasConceptScore W2947693678C3019894029 @default.
- W2947693678 hasConceptScore W2947693678C542903549 @default.
- W2947693678 hasConceptScore W2947693678C71924100 @default.
- W2947693678 hasConceptScore W2947693678C86803240 @default.
- W2947693678 hasLocation W29476936781 @default.
- W2947693678 hasOpenAccess W2947693678 @default.
- W2947693678 hasPrimaryLocation W29476936781 @default.
- W2947693678 hasRelatedWork W2070833530 @default.
- W2947693678 hasRelatedWork W2507710416 @default.
- W2947693678 hasRelatedWork W2582960575 @default.
- W2947693678 hasRelatedWork W2600708922 @default.
- W2947693678 hasRelatedWork W2753452793 @default.
- W2947693678 hasRelatedWork W2789767278 @default.
- W2947693678 hasRelatedWork W2890276829 @default.
- W2947693678 hasRelatedWork W2941597826 @default.
- W2947693678 hasRelatedWork W2952835402 @default.
- W2947693678 hasRelatedWork W2973902249 @default.
- W2947693678 hasRelatedWork W3023081021 @default.
- W2947693678 hasRelatedWork W3034062991 @default.
- W2947693678 hasRelatedWork W3048381650 @default.
- W2947693678 hasRelatedWork W3083470963 @default.
- W2947693678 hasRelatedWork W3095245996 @default.
- W2947693678 hasRelatedWork W3158472363 @default.
- W2947693678 hasRelatedWork W3185014099 @default.
- W2947693678 hasRelatedWork W3196348907 @default.
- W2947693678 hasRelatedWork W3205838204 @default.
- W2947693678 hasRelatedWork W3212180877 @default.
- W2947693678 isParatext "false" @default.
- W2947693678 isRetracted "false" @default.
- W2947693678 magId "2947693678" @default.
- W2947693678 workType "article" @default.